Navigation Links
Schering-Plough Announces Planned Divestiture of Select Animal Health Products in Europe
Date:4/23/2008

pdate any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces; economic factors; and the regulatory process; , among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part I, Item IA. "Risk Factors" in Schering-Plough's 2007 10-K/A.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Schering-Plough Reports Financial Results for First Quarter of 2008
2. Schering-Plough Schedules Conference Call and Webcast for 2008 First Quarter Earnings
3. Schering-Plough Launches Productivity Transformation Program To Confront New Challenges
4. Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
5. Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R)
6. Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
7. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
8. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
9. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
10. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
11. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... (PRWEB) May 23, 2013 The maker ... all types of inventions. They focus on learning practical ... this community gravitate toward bringing their ideas to life ... Biology Movement, works on making projects using biology. Glowing ... of plants to make them glow with bioluminescence genes, ...
(Date:5/23/2013)... Pa. , May 23, 2013 ... research and advisory firms for specialized biopharmaceutical issues, ... hepatologists, and infectious disease specialists reported that in ... patients (e.g., intentionally delaying treatment) in anticipation of ... than six months ago, when only 6 percent ...
(Date:5/23/2013)... 2013 Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" ... host a teleconference to discuss its First Quarter 2013 ... teleconference information is provided below: Date: Thursday, ... (EDT) Dial-in: (800) 875-3456 (U.S.); (800) 648-0973 ... VS22823 For those unable to participate in ...
(Date:5/23/2013)... African Ancestry , Inc., ... of African descent, today announced new product enhancements ... of all races, myDNAmix determines various ancestries included ... Indigenous Americas (Native American), East Asia, West Sub-Saharan ... , Originally launched in late 2011, the enhanced ...
Breaking Biology Technology:Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 2AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 3
... 27 DHA omega-3 innovator,Martek Biosciences announced today that ... featured in new Ricos(R) Cheese Sauce.,Sold to schools throughout ... of,DHA per serving in the standard foodservice packaging of ... 3.5 oz. single serve cup which contains 50 mg,of ...
... III Development and ... -, NEW YORK, and PRINCETON, N.J., Aug. 27 ... Company (NYSE: BMY ) ("companies"),today announced that they ... research, develop and commercialize DGAT-1,inhibitors, a collaboration first announced ...
... launched today a new 200 mg single-use vial ... who have,adjuvant stage III colon cancer and advanced ... efficiency and safety in the,preparation of the injectable ... mg and 100 mg single- use vials. The ...
Cached Biology Technology:life'sDHA(TM) Featured in New Ricos(R) Cheese Sauce 2life'sDHA(TM) Featured in New Ricos(R) Cheese Sauce 3Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program 2Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program 3Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program 4New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 2New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 3New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 4New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 5New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 6New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 7
(Date:5/22/2013)... to genetic engineering drastically reduces the time and ... the workhorses of biotechnology, scientists are reporting. Published ... the method paves the way for more rapid ... cleanup and other activities. , Keith Shearwin and ... of the genetic material DNA into a bacterium,s ...
(Date:5/22/2013)... scientists provide important new details on how climate change ... May 21 in the Journal of Animal Ecology ... accurate predictions and informing policymakers of how species are ... , "There is a growing recognition among biologists that ... another, and that this is going to have very ...
(Date:5/21/2013)... Biologists have known for a long time that ... isn,t well understood, particularly for plants. But it may ... of Australian National University and the U. S. National ... be published 21 May in the journal Nature ... have faster-changing genomes. , Drawing from a database of ...
Breaking Biology News(10 mins):UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5Small but speedy: Short plants live in the evolutionary fast lane 2
... bacteria sticking to surfaces both inside and outside the ... most virulent, antibiotic-resistant infections in humans; however, scientific understanding ... A recent study led by a Syracuse University biologist ... that a complex cascade of enhancer binding proteins (EBPs) ...
... ARLINGTON, Va.The Office of Naval Research (ONR) Global ... defense community members at MAST Europe 2011, June ... science and technology inventions and showcasing the organization,s ... gathers senior leaders from more than 40 countries ...
... and the variety of resources available are the key ... according to a new mathematical model that integrates all ... a process called sympatric speciation. Titled "Factors influencing ... edition of the Journal of Evolutionary Biology . ...
Cached Biology News:Syracuse University biologist discovers key regulators for biofilm development 2Office of Naval Research Global connecting with international naval community at MAST Europe 2011 2The mechanics of speciation 2
These 18x18 square No.1 Corning cover glasses are made from No. 0211 zinc titania glass and are 0.16 to 0.19mm thick....
... hydrophobic cover slips for in situ ... arrays on glass slides., Constant ... do not adsorb probes. , Ready-to-use-Hybri-slips ... use. , Avoid RNA degradation-Hybri-slips are ...
...
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in....
Biology Products: